🔰 SEASONAL FLU IS RISING — AN APPLIED UNANI MIZAJ-BASED APPROACH



India is experiencing a seasonal rise in influenza during the monsoon/post-monsoon period. Recent surveillance reports describe Influenza A(H1N1) pdm09 as the predominant detected Influenza A strain. Most cases are mild/self-limiting, but high-risk and complicated cases require modern clinical management.

❗So, how can we apply Unani Medicine intelligently?

I would approach Nazla-e-Waba’i / influenza-like illness through clinical phenotype + Mizaj, rather than giving one “anti-flu” prescription to everybody.

1️⃣ Balghami / Cold-Wet phenotype

Features: nasal congestion, watery discharge, phlegmatic cough, heaviness, chills.

Mufradat:
Unnab + Sapistan + Behidana;
Zufa + Asl-us-soos where appropriate.

Nuskha:
Joshanda: Behidana 3 g + Unnab 5 + Sapistan 7–9 + Zufa 3 g → decoction, warm, divided doses.

2️⃣ Safrawi / Hot-Dry phenotype

Features: high fever, thirst, dry irritating cough, burning throat, scanty sputum.

Mufradat: Behidana, Sapistan, Unnab, Banafsha.

Nuskha:
Behidana 3 g + Sapistan 7 + Unnab 5 + Banafsha 3 g → warm decoction; adjust according to clinical response.

3️⃣ Mixed / Mu‘tabar clinical phenotype

Fever + myalgia + nasal symptoms + cough with variable sputum.

Here the objective is Taskeen + Tarqiq-e-Balgham + Islah-e-Sadr, without unnecessarily increasing “heat”.

❗Where does Tiryaq-e-Waba’i fit?

Classically it contains Sibr : Murr Makki : Za‘fran = 2:1:1 and has a long-standing prophylactic role in epidemic conditions. A small randomized study in elderly immunocompromised subjects demonstrated immunological changes, but this is not evidence that it treats influenza virus itself.

Therefore, I would regard it as a selected adjunct/preventive Unani formulation—not a substitute for antiviral therapy in severe/high-risk influenza.

The Applied Unani Principle

Diagnose → assess severity → identify Mizaj/clinical phenotype → select Mufradat → construct Murakkab → monitor response → escalate when necessary.

WHO clinical guidance supports antiviral treatment according to severity/risk, while current evidence for Unani formulations remains much less definitive.

Unani excellence is not “one prescription for every flu patient.”

It is Mizaj + phenotype + severity + evidence + timely integration with modern care.

Comments

Popular posts from this blog

🔰Liver-Centric Cholesterol Regulation

🔰Why Does Human Temperament Change Throughout Life? A Unani Perspective on the Four Stages of Sinn

🔰How Genomics Can Help a Unani Physician in Precise Mizaj Evaluation: A New Frontier of Precision Unani Medicine